New diabetes clinical trial: Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Published on: June 04, 2019 at 07:00PM
Condition:   Type2 Diabetes Mellitus
Interventions:   Drug: glucokinase activator;   Drug: Placebo
Sponsor:   PegBio Co., Ltd.
Not yet recruiting